ABSTRACT. Lipase activities were measured at pH 4 and properties of lipoprotein lipase (6,7), whereas a second, measured pH 8 in the placentas of rats made diabetic by streptozo-at pH 4, is probably lysosomal in origin (8) . tocin treatment and also in the placentas of women classiLipoprotein lipase activity in adipose tissue and diaphragm fied as having 1) impaired glucose tolerance or type 2 was found to be reduced in streptozotocin-induced diabetic rats, diabetes, 2) type 1 diabetes with no associated vascular but in the same experiments the lipoprotein lipase-like activity complication, and 3) type 1 diabetes with associated vas-in the placenta was unaffected (9, 10). However, Shafrir and cular disease. In both sets of experiments, the placentas coworkers (4, 9) showed that lipolytic activity in the placentas of were compared with normal control groups. The placental diabetic rats was increased, and they inferred that this was due lipase activity measured at pH 8 was not significantly to an increase in placental "intracellular" lipase activity. Theredifferent in either streptozotocin-treated rats or impaired fore, in the study reported here, we tested the hypothesis that glucose toleranceldiabetic women as compared with con-placental pH 4 lipase activity is increased in the placentas of trols, whereas the lipase activity measured at pH 4 in-diabetic women and rats. We have measured both the pH 8 creased significantly as compared with controls in both lipase and the pH 4 lipase activity in the placentas of streptozospecies. Furthermore, in the women there was a significant tocin-induced diabetic rats and also in the placentas of mothers correlation between placental lipase activity at pH 4 and who were classified as having IGT or type 2 diabetes and those birth weight in impaired glucose tolerance/type 2 diabetes. classified as having type 1 diabetes with or without vascular It is suggested that the increased placental lipase activity disease. may contribute to the increased fetal weight in human diabetic pregnancy, by contributing to the increased fat Chemicals and isotopes. 3H-9-10 trioleyl glycerol (sp act 0.5-1.0 Ci/mmol) was purchased from Amersham International plc Abbreviations (Bucks, UK). Phosphatidylcholine, 9-10 trioleyl glycerol (99%) glycerol, and BSA were all purchased from Sigma Chemical IGT, impaired glucose tolerance Company (Dorset, UK). Heat-inactivated horse serum was purchased from Flow Laboratories (Herts, UK). Streptozotocin was kindly provided by Dr. N. MacLeod (The UpJohn Co., Kalamazoo, MI). Other chemicals were ANALAR grade, purchased Diabetes in pregnancy produces major changes in maternal from BDH (Poole, UK). plasma lipid concentrations (1-3). Plasma triglycerides are ele-
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Streptozotocin-induced diabetes in rats.
Female CSE Wistar vated in both type 2 diabetes and gestational diabetes, whereas rats were made diabetic before mating by a single i.v. adminisin type 1 diabetic patients plasma triglycerides are not signifi-tration of 40 mg/kg of streptozotocin (1 1). Serum glucose was cantly elevated above the level associated with normal pregnancy measured just before killing the animals on d 21 of gestation (2) . The hyperlipidemia of type 2 diabetic pregnancy leads to (term = 22 d). The fetuses and placentas were weighed, and the increased FFA passage across the placenta and may be associated lipase activities at pH 4 and 8 were determined. Mean values with neonatal macrosomia (2) . Furthermore, placentas from were calculated for each animal, and these litter mean values women and rats with severe diabetes have an increase in their were used as the units for statistical analysis for all of the triglyceride/DNA content ratio (3).
measurements.
Placental lipases are thought to play a role in the transfer across
Collection ofplacentasfrom diabetic pregnant women. Placenthe placenta of FFA derived from maternal VLDL (4), It has tas were collected from diabetic women and women with IGT also been proposed that the placenta esterifies fatty acids crossing (12) , all of whom were receiving treatment at St. Mary's Hospital, from the maternal circulation and temporarily stores the triglyc-Manchester, UK. All of the women were at term (37-41 wk) eride. Intracellular lipases could then, when appropriate, hydro-except for one case with vascular disease, who was at 36 wk lyze this stored triglyceride, releasing FFA into the fetal circula-gestation. The clinical details of the diabetic women are given in tion (4, 5) . Table 1 . Subjects in both diabetic and control groups were There appear to be at least two distinct lipase activities in the randomly chosen; we did not impose any exclusion criteria. The placenta. One of the enzymes, assayed at pH 8, has many of the 22 placentas from the diabetic women were, for statistical analysis, first treated as one group and then treated as three subgroups weight (14); none of these patients had renal failure. The lipase activities measured at pH 4 and 8 were compared with those in placentas from a randomly selected control group of normal mothers at term (37-4 1 wk).
Preparation of placentas and lipase assay. After removing the cord and fetal membranes, placentas were washed in saline and chopped into tiny fragments with a pair of scissors, and aliquots were homogenized in a Waring Blender in ice-cold 0.25 M sucrose, 10 mM Tris HCI buffer (pH 8) at a concentration of 20 mg tissue mL-'. The lipase assay, canied out at pH 4 and pH 8, was a modification of the method of Nilsson-Ehle and Schotz (1 5). The assay mixture (0.1 mL) contained (final concentrations) 9-10 trioleyl glycerol (5.66 mM; ratio of unlabeled:labeled = 106:1), phosphatidylcholine (0.35 mM), glycerol (8.5% wt/vol), and BSA (33.3 mg/mL) in phosphate or citrate/KCI buffer (70 mM). In preliminary experiments we found that horse serum (8.5% wt/vol) added to the assay mixture inhibited enzyme activity at pH 4 to 0.5 + 0.22% of control levels in rat (n = 5) and to 10 5 5.6% of control levels in human placentas (n = 5) but had no effect on activity at pH 8 in rat or human placenta. Because pH 4 activity in particular is very high compared with that at pH 8 (see Results), horse serum (at a concentration of 8.5% wt/vol) was added to the lipase assay at pH 8 in all experiments described here to minimize any contribution from other lipolytic activities; no horse serum was present in lipase assays at pH 4.
Blood glucose measurements. These were carried out by the glucose oxidase method. (Yellow Springs 23AM analyzer, Yellow Springs, OH).
Statistical analysis. Data is shown as mean k SD with n being the number of litters for the rat study and the number of placentas in the human study. The t test (unpaired) was used to compare the data from normal (blood glucose 5-8 mM) and diabetic (blood glucose > 10 mM) rats and to compare data from normal and IGT/diabetic patients. Linear regression analysis by the method of least squares was used to relate birth weight and placental lipase activity in the human study.
RESULTS
Streptozotocin-induced diabetic rats. After streptozotocin treatment mean blood glucose concentration for the streptozotocin group was 25.0 + 11.1 mM (n = 7) as compared with 6.0 + 0.2 mM in the control group (n = 5). The resulting rat fetuses were smaller by 28% ( p < 0.05) as compared with a normal control group, but the placental weights were not significantly altered ( Table 2) .
The specific lipase activity in the placentas of streptozotocintreated rats measured at pH 4 was 25% higher ( p < 0.05) than controls, but the sp act at pH 8 was not significantly different ( Fig. 1) . Diabetic pregnant women. When the 22 placentas obtained from IGT/diabetic patients were analyzed as one group, the lipase activity at pH 4 was 6 1 % higher than in the control group ( p < 0.0 l), whereas there was no difference in activity measured rats. *, p < 0.05 compared with control. at pH 8 (Fig. 2) . The data was then split into three subgroups: IGT/type 2 diabetes (n = 1 I), type 1 diabetes without vascular complication (n = 7), and type 1 diabetes with associated vascular disease (n = 4). The lipase activity measured at pH 4 in the IGT/ type 2 diabetes and type 1 diabetes with no associated vascular complication groups was significantly greater than in the control group ( p < 0.05) (Fig. 3) . The lipase activity at pH 4 in the type I diabetes group with associated vascular disease was not significantly different from that of the control group (Fig. 3) . No difference in lipase activities measured at pH 8 was observed between the diabetic subgroups and the control group (data not shown).
Linear regression analysis was carried out between placental lipase activity and birth weight for each of these diabetic subgroups. Only in the case of IGT/type 2 group was there a significant direct correlation with the pH 4 lipase activity [r = 0.85, p < 0.01 ( Fig. 4) J; there was no correlation with type 1 diabetes even when the "with" and "without" vascular disease data groups were pooled.
DISCUSSION
The results of this study clearly show that maternal diabetes results in a marked increase in pH 4 lipase sp act in both rat and human placentas. Lipase activity measured at pH 8 in the placenta was unaffected by diabetes, consistent with previous studies (4, 9) . This lack of effect at pH 8 supports the view that placental lipoprotein lipase like activity is unperturbed by changes in maternal plasma lipid concentrations (4).
Shafrir and coworkers (4, 9) have suggested that FFA derived from maternal VLDL and fatty acids bound to maternal albumin are esterified to placental triglyceride and that intracellular lipases may then bring about release of FFA into the fetal circulation from this stored triglyceride. These authors (4) indirectly assessed "intracellular" lipase activity by incubating placental slices in a medium preloaded with esterified I4C-oleate containing BSA at pH 7.4 and measured the liberated I4C-oleic acid. They demonstrated a significant increase in the amount of I4C FFA released into the medium when placentas from the streptozotocin-treated rats were incubated as compared with a nontreated group. They attributed this increase to intracellular lipase although they did not directly measure lipolytic activity of such an enzyme. The view of these authors that intracellular lipase has a role in fat transfer across the placenta is supported by our data. However, although the lipase activity measured here at pH 4 may be intracellular, it may not be the same lipolytic activity referred to by Shafrir et al. (4) , inasmuch as the pH of their assay was considerably higher.
Pregnant women with IGT or type 2 diabetes have higher circulating plasma triglyceride and FFA concentrations than those with type 1 diabetes (2) . The birth weight of infants born to mothers with diabetes generally shows an increase over a normal population, although the reasons for this are not clearly understood. Although there appears to be a good relationship between maternal obesity and birth weight in IGT, there is little relationship between birth weight and the severity of the glucose impairment (16) . In type 1 diabetes, there have also been many reports of excessive fetal growth in the presence of good diabetic control (17) . This poor relationship is likely to be due to the influence of other factors such as insulin-like growth factors, although this has not so far been definitively demonstrated (1 8). Umbilical blood flow is likely to be impaired in type 1 diabetic patients with vascular disease (19) , and this would obviously affect birth weight. Therefore, the most simple (although unproven at this stage) explanation for the correlation between birth weight and placental pH 4 lipase activity in the IGT/type 2 group is that there is an association between placental and maternally derived lipid and birth weight. The lack of a relationship between birth weight and placental pH 4 lipase activity in the type 1 group may be due to the complicating effects of growth factors and vascular disease on birth weight in these patients. Further studies are needed to elucidate this. In particular, maternal and fetal plasma as well as placental triglyceride and fatty acid concentrations need to be measured in conjunction with measurements of placental lipase activity in diabetic and normal subjects.
Finally, the importance of the correlation of pH 4 placental lipase activity with birth weight reported here is strengthened by our other recent observation that the activity of this enzyme is reduced in the placentas of growth-retarded rat fetuses (20) .
